Showing results (1861-1870 of 1,988) with videos related to

Sort By:
Pageof 199
Cancer Research|July 17, 2001
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinomaS A Nicholson, N T Okby, M A Khan, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald CouplingsHuy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
Geroscience|September 7, 2024
Impact of healthcare system strain on the implementation of ICU sedation practices and encephalopathy burden during the early COVID-19 pandemicJeffrey R Clark, Ayush Batra, Robert A Tessier, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2002
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working groupRonald G Crystal, Peter B Bitterman, Brooke Mossman, et al.
JCI Insight|March 25, 2021
PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancerLucia Liotta, Sebastian Lange, H Carlo Maurer, et al.
Cancer Research|May 15, 1997
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysisM R Emmert-Buck, I A Lubensky, Q Dong, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Assessment Tools of Biopsychosocial Frailty Dimensions in Community-Dwelling Older Adults: A Narrative ReviewVincenzo De Luca, Grazia Daniela Femminella, Roberta Patalano, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Sphingolipid analogues inhibit development of malaria parasitesEsmeralda V S Meyer, Jason J Holt, Kathryn R Girard, et al.
Molecular Pharmacology|February 19, 2026
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptorLeon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
The Journal of Clinical Investigation|February 9, 2022
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategiesAlessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
Pageof 199